Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Janssen Biologics B.V.

02 3Orifarm AB

03 1Pharmachim AB

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

abciximab

Brand Name : ReoPro

Dosage Form : INJEKTIONS-/INFUSIONSVÄTSKA, LÖSNING

Dosage Strength : 2 MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

abciximab

Brand Name : Reopro

Dosage Form : INJEKTIONS-/INFUSIONSVÄTSKA, LÖSNING

Dosage Strength : 2 MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

abciximab

Brand Name : Reopro

Dosage Form : INJEKTIONS-/INFUSIONSVÄTSKA, LÖSNING

Dosage Strength : 2 MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

abciximab

Brand Name : Reopro

Dosage Form : INJEKTIONS-/INFUSIONSVÄTSKA, LÖSNING

Dosage Strength : 2 MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

05

Pharmachim AB

Country
2024 ACI Convention
Not Confirmed
arrow

Pharmachim AB

Country
arrow
2024 ACI Convention
Not Confirmed

abciximab

Brand Name : ReoPro

Dosage Form : INJEKTIONS-/INFUSIONSVÄTSKA, LÖSNING

Dosage Strength : 2 MG/ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank